MedTrace Logo

Mepivacaine Versus Low-Dose Bupivacaine For Primary Total Hip and Knee Arthroplasty

NCT03838874 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 154

Last updated 2021-08-12

Study results available
· View outcomes & findings →

Summary

This research is being done to see if there is a difference between two different spinal anesthetics (Mepivacaine vs. Bupivacaine) as it relates to reducing post-operative complications and the time it takes for subjects to regain mobility after surgery.

Conditions

Interventions

DRUG

Low-Dose Bupivacaine

10 mg (2 mL of 0.5%) administered as an isobaric spinal anesthetic

DRUG

Mepivacaine

70 mg (3.5 mL of 2%) administered as an isobaric spinal anesthetic

Sponsors & Collaborators

Principal Investigators

  • Matthew P Abdel, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-25
Primary Completion
2019-10-29
Completion
2019-10-29
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03838874 on ClinicalTrials.gov